Progressive nuclear factor-κB activation resistant to inhibition by contraction and curcumin in mdx mice

William J. Durham, Sandrine Arbogast, Eric Gerken, Yi Ping Li, Michael B. Reid

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Skeletal muscle of patients with Duchenne-type muscular dystrophy and mdx mice exhibits elevated activity of the transcription factor NF-κB (nuclear factor-κB), which may play a role in muscle catabolism. We measured skeletal muscle NF-κB activity in mdx mice at three ages (10 days, 4 weeks, and 8 weeks) to test the hypothesis that NF-κB activity is elevated in an age-dependent manner in these mice. In addition, we tested the hypothesis that NF-κB activity could be reduced in mdx skeletal muscle by dietary supplementation with curcumin (1% w/v) or by fatiguing muscle contractions. We found that NF-κB activity was elevated at 4 and 8 weeks of age but not at 10 days, and was resistant to inhibition by either fatiguing contractions or dietary curcumin. We conclude that NF-κB activity is elevated in dystrophic skeletal muscle in an age-related manner and is resistant to inhibition by physiological and pharmacological means. These findings are consistent with a role for NF-κB activation in dystrophic muscle wasting but suggest that predicted interventions such as exercise or inhibitors of the early steps in the NF-κ activation pathway may not be effective and that targeted research is needed to identify novel therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)298-303
Number of pages6
JournalMuscle and Nerve
Volume34
Issue number3
DOIs
StatePublished - Sep 2006
Externally publishedYes

Fingerprint

Inbred mdx Mouse
Curcumin
Skeletal Muscle
Muscles
Duchenne Muscular Dystrophy
Muscle Contraction
Dietary Supplements
Transcription Factors
Pharmacology
Exercise
Research

Keywords

  • Muscle damage
  • Muscular dystrophy
  • Supplement
  • Transcription factor

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Progressive nuclear factor-κB activation resistant to inhibition by contraction and curcumin in mdx mice. / Durham, William J.; Arbogast, Sandrine; Gerken, Eric; Li, Yi Ping; Reid, Michael B.

In: Muscle and Nerve, Vol. 34, No. 3, 09.2006, p. 298-303.

Research output: Contribution to journalArticle

Durham, William J. ; Arbogast, Sandrine ; Gerken, Eric ; Li, Yi Ping ; Reid, Michael B. / Progressive nuclear factor-κB activation resistant to inhibition by contraction and curcumin in mdx mice. In: Muscle and Nerve. 2006 ; Vol. 34, No. 3. pp. 298-303.
@article{1e4acd16756f410081908e2b1968da20,
title = "Progressive nuclear factor-κB activation resistant to inhibition by contraction and curcumin in mdx mice",
abstract = "Skeletal muscle of patients with Duchenne-type muscular dystrophy and mdx mice exhibits elevated activity of the transcription factor NF-κB (nuclear factor-κB), which may play a role in muscle catabolism. We measured skeletal muscle NF-κB activity in mdx mice at three ages (10 days, 4 weeks, and 8 weeks) to test the hypothesis that NF-κB activity is elevated in an age-dependent manner in these mice. In addition, we tested the hypothesis that NF-κB activity could be reduced in mdx skeletal muscle by dietary supplementation with curcumin (1{\%} w/v) or by fatiguing muscle contractions. We found that NF-κB activity was elevated at 4 and 8 weeks of age but not at 10 days, and was resistant to inhibition by either fatiguing contractions or dietary curcumin. We conclude that NF-κB activity is elevated in dystrophic skeletal muscle in an age-related manner and is resistant to inhibition by physiological and pharmacological means. These findings are consistent with a role for NF-κB activation in dystrophic muscle wasting but suggest that predicted interventions such as exercise or inhibitors of the early steps in the NF-κ activation pathway may not be effective and that targeted research is needed to identify novel therapeutic strategies.",
keywords = "Muscle damage, Muscular dystrophy, Supplement, Transcription factor",
author = "Durham, {William J.} and Sandrine Arbogast and Eric Gerken and Li, {Yi Ping} and Reid, {Michael B.}",
year = "2006",
month = "9",
doi = "10.1002/mus.20579",
language = "English (US)",
volume = "34",
pages = "298--303",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Progressive nuclear factor-κB activation resistant to inhibition by contraction and curcumin in mdx mice

AU - Durham, William J.

AU - Arbogast, Sandrine

AU - Gerken, Eric

AU - Li, Yi Ping

AU - Reid, Michael B.

PY - 2006/9

Y1 - 2006/9

N2 - Skeletal muscle of patients with Duchenne-type muscular dystrophy and mdx mice exhibits elevated activity of the transcription factor NF-κB (nuclear factor-κB), which may play a role in muscle catabolism. We measured skeletal muscle NF-κB activity in mdx mice at three ages (10 days, 4 weeks, and 8 weeks) to test the hypothesis that NF-κB activity is elevated in an age-dependent manner in these mice. In addition, we tested the hypothesis that NF-κB activity could be reduced in mdx skeletal muscle by dietary supplementation with curcumin (1% w/v) or by fatiguing muscle contractions. We found that NF-κB activity was elevated at 4 and 8 weeks of age but not at 10 days, and was resistant to inhibition by either fatiguing contractions or dietary curcumin. We conclude that NF-κB activity is elevated in dystrophic skeletal muscle in an age-related manner and is resistant to inhibition by physiological and pharmacological means. These findings are consistent with a role for NF-κB activation in dystrophic muscle wasting but suggest that predicted interventions such as exercise or inhibitors of the early steps in the NF-κ activation pathway may not be effective and that targeted research is needed to identify novel therapeutic strategies.

AB - Skeletal muscle of patients with Duchenne-type muscular dystrophy and mdx mice exhibits elevated activity of the transcription factor NF-κB (nuclear factor-κB), which may play a role in muscle catabolism. We measured skeletal muscle NF-κB activity in mdx mice at three ages (10 days, 4 weeks, and 8 weeks) to test the hypothesis that NF-κB activity is elevated in an age-dependent manner in these mice. In addition, we tested the hypothesis that NF-κB activity could be reduced in mdx skeletal muscle by dietary supplementation with curcumin (1% w/v) or by fatiguing muscle contractions. We found that NF-κB activity was elevated at 4 and 8 weeks of age but not at 10 days, and was resistant to inhibition by either fatiguing contractions or dietary curcumin. We conclude that NF-κB activity is elevated in dystrophic skeletal muscle in an age-related manner and is resistant to inhibition by physiological and pharmacological means. These findings are consistent with a role for NF-κB activation in dystrophic muscle wasting but suggest that predicted interventions such as exercise or inhibitors of the early steps in the NF-κ activation pathway may not be effective and that targeted research is needed to identify novel therapeutic strategies.

KW - Muscle damage

KW - Muscular dystrophy

KW - Supplement

KW - Transcription factor

UR - http://www.scopus.com/inward/record.url?scp=33748070833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748070833&partnerID=8YFLogxK

U2 - 10.1002/mus.20579

DO - 10.1002/mus.20579

M3 - Article

VL - 34

SP - 298

EP - 303

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 3

ER -